National Cancer Institute, www.cancer.gov
Office of Cancer Centers
Downloads  |  FAQ  |  Site Map
Cancer Centers Grants and Funding News and Events About Us

Home > News & Events > Recent Communications

Recent Communications

NCI Cancer Centers Program Congratulates the Comprehensive Cancer Center Recipients of the 2009 Nobel Prize in Physiology or Medicine

The NCI Cancer Centers Program congratulates the 2009 Nobel Prize in Medicine recipients and their respective institutions. This year’s Nobel Prize in Physiology or Medicine was jointly awarded to Elizabeth H. Blackburn, Ph.D., Carol W. Greider, Ph.D., and Jack W. Szostak, Ph.D., for the discovery of “how chromosomes are protected by telomeres and the enzyme telomerase.”

2009 Nobel Laureates in Physiology or Medicine

  • Elizabeth H. Blackburn, Ph.D.
    University of California, San Francisco
    (Comprehensive Cancer Center)
  • Carol W. Greider, Ph.D.
    Johns Hopkins University School of Medicine
    (Comprehensive Cancer Center)
  • Jack W. Szostak, Ph.D.
    Dana Farber/Harvard Medical School/ Massachusetts General Hospital
    (Comprehensive Cancer Center)
—posted 12/16/2009


Standardized/Harmonized Clauses for Clinical Trial Agreements


The National Cancer Institute (NCI) and the CEO Roundtable on Cancer jointly sponsored an effort to develop common language for use in the contract agreements that govern clinical trials. The clauses were developed because negotiation of clinical trial agreements between industry and academic medical centers is viewed as one of the key barriers to timely initiation of clinical trials.

The clauses are based on a confidential, third party expert analysis of approximately 50 redacted copies of final negotiated clinical trial agreements provided by 14 representative NCI-designated Cancer Centers and the 11 pharmaceutical companies of the CEO Roundtable Life Sciences Consortium. The analysis revealed that key concepts with regard to intellectual property, subject injury, indemnification, data, confidentiality, and publication rights showed greater than 67% convergence across the agreements demonstrating that negotiations frequently reach a common endpoint for those concepts. The proposed clauses provide model language embodying those key concepts.

The Proposed Standardized/Harmonized Clauses for Clinical Trial Agreements are provided for informational purposes only. Their use is voluntary and they are designed to serve as a starting point for contract negotiations. For more information, please contact the Coordinating Center for Clinical Trials at nciccct@mail.nih.gov. Two versions of the document are available here:

Agreement (.pdf format)
Agreement (.doc format)

They are also posted on our Download page.



»View Communication Archives